Similarly, the demethylase ALKBH5 demonstrates opposing functions in HCC: it inhibits malignancy and progression [61] in certain cases and promotes oncogenesis [133] by stabilizing pro-oncogenic mRNA in HBV-related HCC. This evidence concerns the gene ALKBH5 and hepatocellular carcinoma.